Ethan Naquin

Ethan Naquin

Ponce Health Sciences University, St. Louis, St. Louis, Missouri, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
WKWilliam Kardasis
William Kardasis
Ethan NaquinEthan Naquin
Ethan Naquin
RGRicha Garg
Richa Garg
TATejas Arun
Tejas Arun
JGJyotsna S. Gopianand
Jyotsna S. Gopianand
Jaya P Gnana-PrakasamJaya P Gnana-Prakasam
Jaya P Gnana-Prakasam
Iron is an essential micronutrient for athletes, intricately linked to their performance, by regulating cellular respiration and metabolism. Impaired iron levels in the body can significantly hinder athletic performance. The increased demand for iron due to exercise, coupled with potential dietary iron insufficiencies, particularly among endurance athletes, amplifies the risk of iron deficiency. Moreover, prolonged exercise can impact iron absorption, utilization, storage, and overall iron concentrations in an athlete. On the contrary, iron overload may initially lead to enhanced performance; however, chronic excess iron intake or underlying genetic conditions can lead to detrimental health consequences and may negatively impact athletic performance. Excess iron induces oxidative damage, not only compromising muscle function and recovery, but also affecting various tissues and organs in the body. This narrative review delineates the complex relationship between exercise and iron metabolism, and its profound effects on athletic performance. The article also provides guidance on managing iron intake through dietary adjustments, oral iron supplementation for performance enhancement in cases of deficiency, and strategies for addressing iron overload in athletes. Current research is focused on augmenting iron absorption by standardizing the route of administration while minimizing side effects. Additionally, there is ongoing work to identify inhibitors and activators that affect iron absorption, aiming to optimize the body’s iron levels from dietary sources, supplements, and chelators. In summary, by refining the athletic diet, considering the timing and dosage of iron supplements for deficiency, and implementing chelation therapies for iron overload, we can effectively enhance athletic performance and overall well-being.

16 September 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
Ethan NaquinEthan Naquin
Ethan Naquin
RGRicha Garg
Richa Garg
WCWilliam Jason Chen
William Jason Chen
Eshani KarmakarEshani Karmakar
Eshani Karmakar
APAmogh Prasad
Amogh Prasad
Jaya P Gnana-PrakasamJaya P Gnana-Prakasam
Jaya P Gnana-Prakasam
Iron is an essential micronutrient integral to ocular physiology, supporting biochemical processes such as mitochondrial respiration, DNA synthesis and phototransduction. Disruptions in systemic or local iron homeostasis, whether due to overload or deficiency, have been increasingly implicated in the pathogenesis of a broad range of anterior and posterior segment ocular disorders. Iron deficiency may compromise retinal bioenergetics, impair cellular repair, and increase susceptibility to oxidative stress, while iron overload facilitates the generation of reactive oxygen species, contributing to lipid peroxidation, mitochondrial dysfunction, and ferroptosis. Dysregulated iron metabolism has been associated with several ocular pathologies, including age-related macular degeneration, diabetic retinopathy, glaucoma, retinal detachment, cataracts, and anemic retinopathy. The eye possesses specialized iron regulatory mechanisms involving proteins such as transferrin, ferritin, ferroportin, and hepcidin that govern iron transport, storage, and export across ocular barriers. Aberrations in these pathways are now recognized as contributing factors in disease progression. This narrative review explores the complex dual role of iron overload and deficiency in ocular diseases. It highlights the molecular mechanisms underlying iron-mediated pathologies in both the posterior and anterior segments of the eye, along with the clinical manifestations of iron imbalance. Current therapeutic approaches are discussed, including oral and parenteral iron supplementation for deficiency and emerging chelation-based or antioxidant strategies to address iron overload, while highlighting their limitations. Key challenges remain in developing targeted ocular delivery systems that optimize bioavailability and minimize systemic toxicity. Hence, maintaining iron homeostasis is critical for visual function, and further research is needed to refine therapeutic interventions and clarify the mechanistic role of iron in ocular health and disease.

10 October 2020 in Environmental Quality Management
Verified
Journal Article
Closed access
PDF file
Ethan NaquinEthan Naquin
Ethan Naquin
HSHiba Soorya
Hiba Soorya
COChristopher Oubre
Christopher Oubre
SRSarah Rogers
Sarah Rogers
Ramaraj BoopathyRamaraj Boopathy
Ramaraj Boopathy

20 March 2022 in Environmental Quality Management
Verified
Journal Article
Closed access
Ethan NaquinEthan Naquin
Ethan Naquin
Ramaraj BoopathyRamaraj Boopathy
Ramaraj Boopathy

27 December 2025 in bioRxiv
Verified
Preprint
Open access
RGRicha Garg
Richa Garg
EKEshani Karmakar
Eshani Karmakar
DDDavid DeBruin
David DeBruin
SPShauna Prasad
Shauna Prasad
Ethan NaquinEthan Naquin
Ethan Naquin
Jaya P Gnana-PrakasamJaya P Gnana-Prakasam
Jaya P Gnana-Prakasam
Ketone body metabolism serves as an auxiliary regulator of cellular energetics and redox balance, particularly during prolonged fasting and carbohydrate restriction, yet its role in retinal homeostasis under physiological conditions remains poorly defined. β-hydroxybutyrate dehydrogenase 1 (BDH1) is a mitochondrial enzyme that interconverts acetoacetate and β-hydroxybutyrate, and is required for efficient ketone utilization. Here, we investigated the impact of impaired endogenous ketone metabolism on retinal function using global and retinal pigment epithelium (RPE)—specific BDH1 knockout (KO) mice. Global BDH1 KO mice showed reduced circulating β-hydroxybutyrate and blunted fasting-induced ketone elevations, accompanied by ganglion cell loss, structural abnormalities on fundus and OCT imaging, and diminished scotopic and photopic electroretinogram (ERG) a- and b-wave amplitudes, consistent with impaired photoreceptor responses and downstream bipolar and Müller cell signaling. In contrast, RPE-specific BDH1 KO mice exhibited no changes in ERG responses or retinal morphology. Transcriptomic and molecular analyses in global KO retinas revealed disrupted Müller cell homeostasis, including reduced CAMKII-CREB activation, which is required for EAAT1 glutamate transporter expression. Administration of exogenous β-hydroxybutyrate, in vitro and in vivo, restored CAMKII—CREB—EAAT1 signaling, glutamate uptake, and antioxidant gene expression in BDH1 KO mice, demonstrating a central role for ketone bodies in Müller cell metabolic support, glutamate homeostasis, and redox balance. Together with reduced BDH1 expression in human AMD retinas, these findings identify the BDH1—β-hydroxybutyrate axis as a critical metabolic pathway for Müller cell function and retinal integrity, and highlight ketone metabolism as a potential therapeutic target in degenerative retinal diseases.